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Summary blurb  
Sox2 interacts with RNA-binding proteins and diverse RNAs 
 
 
Abstract  
Sox2 is a master transcriptional regulator of embryonic development. In this study, we 
determined the protein interactome of Sox2 in the chromatin and nucleoplasm of mouse 
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embryonic stem (mES) cells. Apart from canonical interactions with pluripotency-regulating 
transcription factors, we identified interactions with several chromatin modulators, including 
members of the heterochromatin protein 1 (HP1) family, suggesting a role of Sox2 in 
chromatin-mediated transcriptional repression.  Sox2 was also found to interact with RNA 
binding proteins (RBPs), including proteins involved in RNA processing. RNA 
immunoprecipitation followed by sequencing revealed that Sox2 associates with different 
messenger RNAs, as well as small nucleolar RNA Snord34 and the non-coding RNA 7SK. 
7SK has been shown to regulate transcription at regulatory regions, which could suggest a 
functional interaction with Sox2 for chromatin recruitment. Nevertheless, we found no 
evidence of Sox2 modulating recruitment of 7SK to chromatin when examining 7SK 
chromatin occupancy by Chromatin Isolation by RNA Purification (ChIRP) in Sox2 depleted 
mES cells. In addition, knockdown of 7SK in mES cells did not lead to any change in Sox2 
occupancy at 7SK-regulated genes. Thus, our results show that Sox2 extensively interact with 
RBPs, and suggest that Sox2 and 7SK co-exist in a ribonucleoprotein complex whose 
function is not to regulate chromatin recruitment, but might rather regulate other processes in 
the nucleoplasm. 
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Introduction 
 
The defining features of embryonic stem (ES) cells are self-renewal and pluripotency, both of 
which are governed by complex gene regulatory networks. The master transcriptional 
regulator, Sox2 (SRY-box containing gene 2) lies at the center of these programs (Avilion et 
al., 2003; Takahashi and Yamanaka, 2006). Sox2 binds to DNA via its highly conserved 
HMG-box domain, often in co-operation with other transcription factors of the pluripotency 
network, such as Oct4 and Nanog (Avilion et al., 2003; Gao et al., 2012), to elicit programs 
that either maintain ES cell identity or lead towards differentiation of multiple lineages 
(Wang et al., 2012; Zhang and Cui, 2014). ES cells harbour a unique epigenetic landscape 
defined by permissive chromatin with a more dispersed heterochromatin along with bivalent 
histone marks placed on developmentally important genes (Gaspar-Maia et al., 2011). This 
plasticity forms a crucial part of the regulatory circuit and is contributed by a dynamic and 
reciprocal interaction of epigenetic modulators such as histone/DNA modifiers and 
nucleosome remodellers with the core pluripotency transcription factors in ES cells (Delgado-
Olguín and Recillas-Targa, 2011; Guenther et al., 2010; Kashyap et al., 2009). This cross-talk 
between key transcription factors, such as Sox2, and chromatin modulators also occurs in 
other multipotent cells types, such as neural stem cells (Engelen, Akinci et al., 2011). Non-
coding RNAs (ncRNAs) have also emerged as important regulators of chromatin status and 
transcription and are likely to operate within a highly integrated network of transcription 
factors and chromatin modulators to influence key cellular events (Huo and Zambidis, 2013; 
Wright and Ciosk, 2013). 
 
In this study, we identified several chromatin modulators and RNA binding proteins 
interacting with Sox2 in different nuclear fractions of embryonic stem (ES) cells, by Stable 
Isotope Labelling by Aminoacids in Cell culture (SILAC) technology (Ong et al., 2002), 
coupled with immunoprecipitation and mass spectrometry-based quantitative proteomics. In 
addition, we affinity-purified Sox2 from mES cell extracts and identified associated RNAs 
through RNA-sequencing, including the small nuclear RNA (snRNA) 7SK and small 
nucleolar RNA (snoRNA) Snord34. 7SK is known to regulate transcriptional elongation by 
sequestering positive transcription elongation factor b (P-TEFb), a critical factor required for 
Pol II promoter proximal pause-release, in a catalytically inactive small nuclear 
ribonucleoprotein complex (Peterlin et al., 2012). We have previously shown that 7SK can 
regulate genes involved in lineage commitment, suggesting directed recruitment to specific 
regulatory regions in mES cells (Castelo-Branco et al., 2013). Nevertheless, we could find no 
evidence of Sox2 regulating 7SK recruitment to chromatin, or vice-versa, suggesting that the 
interactions between 7SK and Sox2 might be involved in other processes.  In sum, our data 
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suggests that Sox2 is present in complexes containing chromatin regulators and RNA binding 
proteins, which indicates that Sox2 may be involved in their functions and that its role as a 
transcriptional regulator might  involve association with specific RNAs. 
 
Results  
Sox2 has been shown to be a key player in maintaining the pluripotent state of ES cells. In 
order to identify the protein complexes associated with Sox2 in mouse pluripotent cells, we 
combined affinity purification of biotin-tagged recombinant proteins with SILAC quantitative 
proteomics (Figure 1A). To explore the protein interactors of Sox2 in different nuclear 
fractions, we prepared native chromatin and nucleoplasm extracts of 13C6-labelled J1 ES cells 
expressing Sox2 biotinylated by BirA (bioSox2) and 12C6-labelled J1 control ES cells, 
expressing only BirA. Protein complexes interacting with Sox2 were immunoprecipitated 
with streptavidin beads and mixed 1:1 with control samples prior to proteomic analysis by 
mass spectrometry. For increased specificity, we also performed reverse labelling (13C6-
labelled J1 control ES cells and 12C6-labelled bioSox2 J1 ES cells). As previously reported 
(Wang et al., 2006), the levels of biotinylated Sox2 were lower than endogenous Sox2 (Figure 
1B). In order to determine if the somewhat elevated Sox2 expression led to ectopic 
differentiation, as previously reported (Kopp et al., 2008), transcriptomic profiles of bioSox2 
and control J1 mES cell lines were compared and were found to be very similar (Pearson 
correlation coefficient R = 0.97; Supplementary Figure 1A). Amongst the few genes that were 
differentially expressed between the two cell lines, there was Sox21 whose elevated 
expression have been previously reported to trigger ES cell differentiation (Mallanna et al., 
2010). Nevertheless, bioSox2 cells exhibited an undifferentiated morphology in culture (not 
shown) and no other differentiation markers were found to be enriched in bioSox2 compared 
to its control cell line (Supplementary Table 1). 
 
For quantitative proteomics comparisons, proteins that showed at least two-fold enrichment in 
bioSox2 over control in both forward and reverse labelling were considered for analysis. As 
expected, Pou5f1 (Oct4), one of the master transcription factors of the core pluripotency 
network as well as other partner factors involved in stem cell maintenance such as Tbx3, 
Sall4, Esrrb and members of the Klf family of transcription factors were found to interact 
with Sox2 in the nucleoplasm (Figure 1C, Supplementary Table 2). Tbx3 and Sall4 were also 
found in the chromatin fraction (Figure 1D, Supplementary Table 3). Several chromatin 
remodelers such as Brg1-associated factors (Baf60a, Baf155, Baf57) and Chd4 (catalytic 
subunit of Nucleosome-remodelling comlex (NuRD)), essential for ES cell renewal, along 
with other chromatin modifiers like HP1 α, β, γ (Cbx5, 1 and 3), Myst4, Sin3a, Kdm5b, Pcgf2 
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and Eed were recovered in the chromatin fraction (Figure 1D, Supplementary Figure 1B, 
Supplementary Table 2). Interestingly, we could also find Sox2 association with chromatin 
regulators such as Trim28, Hdac1 and HP1γ in the nucleoplasm fraction. We confirmed the 
interaction of Sox2 with HP1 proteins using recombinant human Sox2 (Supplementary Figure 
1C) or ES cell nucleoplasm extracts (Supplementary Figure 1D). To further investigate the 
nature of these interactions, domains from both HP1α and HP1β along with their full lengths 
were used to co-immunoprecipitate recombinant Sox2. Different domains in both proteins 
contributed towards interacting with Sox2 (Supplementary Figure 1E).  
 
Analysis of gene ontology terms confirmed that Sox2 interactors were enriched for regulators 
of transcription, but also indicated that a subset of the interactors had RNA recognition motifs 
(Figure 1E and F). Indeed, heterogenous nuclear riboproteins such as hnRNPM, 
hnRNPC1/C2, hnRNPF, hnRNP2 (Fox2), hnRNPD0, hnRNPH1, hnRNPU and other RNA 
binding proteins involved in splicing/post-transcriptional processes such as Ddx3, Ddx5 and 
Ddx17 were detected as Sox2 interactors in the nucleoplasm fraction, while Fubp2, Fubp3, 
Rbm38, hnRNPA2/B1, Prp19, Prp8, Magoh and Srsf1 were detected in the chromatin fraction 
(Supplementary Tables 2 and 3). Moreover, many of the chromatin regulators observed to 
interact with Sox2  have been shown to interact with RNA, including HP1 (Muchardt et al., 
2002). Nevertheless, we observed that the interaction between Sox2 and HP1α/β persisted 
upon RNAse A treatment (Supplementary Figure 1D), indicating that the observed interaction 
is not dependent on RNAs. In sum, these data suggest that Sox2 can be a component of 
ribonucleoprotein complexes in mES cells. 
 
To examine which RNAs could be associated with these complexes, we performed two 
independent immunoprecipitations of bioSox2 from formaldehyde cross-linked J1 ES cells, 
followed by poly(A)-neutral RNA-seq (Figure 2A). While long ncRNAs were not found 
enriched upon Sox2 pull down, we detected an enrichment of a restricted subset of RNAs 
(Figure 2E and Supplementary Table 4), including mRNAs and two non-coding RNAs, the 
snRNA 7SK and snoRNA Snord34 in both experiments (Figure 2B and Supplementary Table 
4). In order to validate the interaction of 7SK and Snord34 RNAs with Sox2 protein, we 
performed qRT-PCR following RNA immunoprecipitation (RIP) with biotinylated Sox2, 
Oct4 and Nanog, as well as RIP with antibodies against endogenous Sox2 and other 
pluripotency transcription factors (Supplementary Figure 1F, G). These experiments 
confirmed the pulldown of 7SK and Snord34 by Sox2. We observed that 
immunoprecipitation of other pluripotency transcription factors, such as Oct4, Nanog and 
Klf4 could also pull down these non-coding RNAs, albeit to a lower extent, in line with their 
co-existence in complexes in the nucleus (Supplementary Figure 1F). Interestingly, we found 
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specific interaction of transcription factors with their own mRNA (except for Sox2 mRNA) 
(Supplementary Figure 1G), which could be due to crosslinking of the mRNA and protein 
during translation, or reflect recruitment of the mRNA by the respective transcription factor, 
in a similar manner as it has been described in Drosophila for proteins of the male-specific 
lethal (MSL) complex (Johansson et al., 2011). 
 
Recently, 7SK was shown to occupy promoters and enhancers to regulate transcription via 
association with different molecular partners (Flynn et al., 2016). Given that they are both 
transcriptional regulators, the observed interaction between 7SK and Sox2 could play a role in 
their recruitment to the chromatin. To assess whether genomic recruitment of 7SK is altered 
in the absence of Sox2, we performed Chromatin Isolation by RNA Purification (ChIRP) with 
even and odd sets of probes to 7SK (Flynn et al., 2016) in a doxycycline inducible Sox2-
knock out mES cell line and compared it with controls treated with DMSO. As a negative 
control, a single probe against LacZ mRNA was used (Figure 3A). The ChIRP set up allows 
us to pull down genomic regions and proteins cross-linked to proximal 7SK with antisense 
biotinylated probes, either in presence or absence of cellular Sox2. After the pull down, any 
interacting protein is digested away and the remaining DNA is sequenced. In this way, we 
were able to efficiently retrieve 7SK, although the percentage of retrieval was variable 
between odd and even pools (Figure 3B), as previously reported for ChIRP experiments (Chu, 
Qu et al., 2011). 7SK-specific probes did not retrieve GAPDH or the abundant nuclear 
ncRNA MALAT1, and the negative control showed negligible enrichment of 7SK ncRNA 
(Figure 3B). Consistent with previous reports (Chu et al., 2011), the overlap between odd and 
even probes in ChIRP was low. We nevertheless could identify 303 robust peaks common to 
both odd and even data sets but depleted for LacZ binding, in DMSO and doxycycline treated 
samples (Supplementary Table 5). In our two replicate ChIRP experiments, we saw 583 
robust peaks for the first experiment (Supplementary Table 6) and 2,006 robust peaks for the 
second experiment (Supplementary Table 7). However, whilst a small difference is seen 
between the doxycycline induced Sox2 KO samples and the control conditions, with a slight 
increase in the doxycycline induced samples, analysis of the change in read counts at each 
peak using an unpaired t-test showed no significant effect at any of the 303 peaks (Figure 
3C). Therefore, Sox2 appears not to be involved in the recruitment of 7SK snRNA to 
chromatin. 
 
We then investigated whether 7SK ncRNA could instead have an impact in the association of 
Sox2 to specific regions on the chromatin. For this purpose, Chromatin Immunoprecipitation 
(ChIP) was performed with an antibody against endogenous Sox2 in mES cells where 7SK 
was depleted with an antisense oligonucleotide (ASO) targeting its 3’ end (Castelo-Branco et 
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al., 2013), which was then followed by qPCR (Figure 4A,D). In order to choose suitable 
candidate target regions, 23,563 Sox2 peaks associated with annotated genes (7,053 unique 
genes) from previously published ChIP-Seq experiment in mES cells (Whyte et al., 2013), 
7SK occupied regions from our ChIRP dataset with 303 robust peaks (144 unique genes) and 
the 7SK occupied regions in a previously published ChIRP seq data set (Flynn et al., 2016)  
with 50,071 peaks (12,892 unique genes) were compared. Whilst our 7SK occupied gene list 
was significantly smaller, 90.3% of genes identified in our screen were also identified by 
Flynn et al. There was a significant overlap between the Sox2- and 7SK-occupied genes, with 
54.2% and 41.5% of genes from ours and Flynn’s 7SK ChIRP datasets respectively also 
showing Sox2 occupancy (Figure 4C, Supplementary table 8). Nevertheless, when centering 
ChIRP reads at the Sox2 binding peaks, we could not find a clear correlation between 7SK 
and Sox2 occupancy (Figure 4B). Out of the genes that were found to bind both 7SK and 
Sox2, Kdm2b, Celf2 and Klf12 were chosen for ChIP-qPCR analysis, along with other regions 
known to be occupied by Sox2 (Pouf51 and Nanog) or shown to be regulated upon 7SK 
knock down (Dll1) (Castelo-Branco et al., 2013).  We observed Sox2 occupancy at regulatory 
regions of Pou5f1 (Oct4), Nanog, Kdm2b, Celf2 and Klf12, but not at the negative control 
(intron of Sox10) (Figure 4E).  However, knockdown of 7SK (Figure 4D) did not lead to 
significant changes in Sox2 binding (Figure 4E). Thus, snRNA 7SK and transcription factor 
Sox2, though present in the same complex, are not involved in reciprocal recruitment to these 
specific regions of chromatin. 
 
Discussion 
Sox2 is known to exist in high molecular weight complexes, the protein interactome of which 
is highly dependent on the cellular context as well as on the purification and mass 
spectrometric methods used to isolate and determine the interactome. Our data, consisting of 
124 proteins, provides a resource for the interactome of Sox2 in mESCs in different nuclear 
fractions. About 23% of our Sox2 interactors overlap with previously published Sox2 
interactome data from the studies of Gao et al. and Mallana et al. (Supplementary Table 9). 
Given the highly integrated networks operating between different pluripotency factors, about 
6% and 11% of Sox2 interactors from this study were also a part of protein complexes found 
interacting with Nanog (Wang et al., 2006) and Oct4 (van den Berg et al., 2010) respectively 
(Supplementary Table 9). Therefore, most of the associations reported here are novel. Our 
results highlight putative novel functions of the transcription factor Sox2 as a constituent of 
ribonucleoprotein complexes containing RNA splicing and processing proteins, which is in 
line with the increasing connection between transcriptional regulation and RNA processing 
factors (Pandit et al., 2008)  
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Our data also indicated that Sox2 in present in complexed which include specific RNAs, such 
as mRNAs and the ncRNA 7SK. We have previously shown that 7SK represses a subset of 
genes with active or bivalent chromatin marks in mES cells, along with those involved in 
lineage specification (Castelo-Branco et al., 2013). Both Sox2 and Sox10 have been shown to 
regulate transcriptional elongation of myelin genes in Schwann cells by interacting directly 
with P-TEFb (Arter and Wegner, 2015), which is a primary regulatory target of 7SK. In 
addition, Poly ADP-ribose polymerase 1 (PARP-1), another Sox2 interactor in our study, was 
recently shown to facilitate and stabilize Sox2 binding to high nucleosome harbouring euchromatic 
regions (Liu and Kraus, 2017). PARP-1 also ADP-ribosylates and inhibits the negative elongation 
factor (NELF), thereby allowing transcriptional elongation to proceed (Gibson et al., 2016). 
Previous studies have also hinted at KAP1/Trim28 (interactor of Sox2 in this study) mediated 
recruitment of inactive P-TEFb in complex with 7SK to promoter proximal regions needing a 
transcription factor or other DNA binding proteins to interface with chromatin (D’Orso, 
2016). Hence, the association of 7SK with Sox2 could be similarly important in modulating 
transcriptional programs dependent on Sox2 in ES cells. ATAC-seq following knock down of 
7SK in mouse ES cells resulted in a reduction of Sox2 transcription factor footprint on 
enhancer elements (Flynn et al., 2016). Nevertheless, our data indicates that such a function 
would not be dependent on mutual modulation of recruitment to chromatin.  
 
Long non-coding RNAs are now thought to be integral to the pluripotency circuit of ES cells 
(Dinger et al., 2008; Guttman et al., 2011; Loewer et al., 2010). LncRNAs involved in 
pluripotency maintenance and neurogenesis (Ng et al., 2012) including lncRNA RMST were 
shown to interact with Sox2 (Ng et al., 2013).  Previous studies investigating Sox2 protein 
interactome in ES cells as well as other cell types have also found proteins with RNA binding 
capability (Cox et al., 2013; Fang et al., 2011; Gao et al., 2012; Zhou et al., 2016) with one 
in-vitro study implicating the Sox2 HMG domain in binding RNA (Tung et al., 2010). We 
detect a limited number of RNAs interacting with Sox2, which includes ncRNAs, 7SK and 
Snord34. Our interactome analysis indicates two RNA-binding proteins that could mediate 
association of Sox2 with 7SK, namely Srsf1 and hnRNAPA2/B1. Srsf1 along with Srsf2, 
were shown to associate with gene promoters in a 7SK dependent manner and play a direct 
role in transcription pause release (Ji et al., 2013). HnRNPA2/B1 specifically interacts in the 
nucleoplasm with a portion of 7SK that is not in complex with its canonical partners, 
HEXIM1 and P-TEFb, and is involved in dynamic remodeling of 7SK snRNP (Barrandon et 
al., 2007; Van Herreweghe et al., 2007). Thus Sox2 might be involved in processes 
downstream of transcriptional initiation. It is also possible that interaction of Sox2 with 
snoRNAs and mRNAs might regulate other chromatin related processes. Interestingly, 
snoRNAs have been recently shown to be present at the chromatin (Li, Zhou et al., 2017, 
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Sridhar, Rivas-Astroza et al., 2017) and regulate chromatin/nuclear structure (Schubert, Pusch 
et al., 2012). Alternatively, it remains a possibility that the association between Sox2 and the 
RNAs reported here is a consequence of their proximity on DNA and nucleoplasm and not 
necessarily due to any functional relationship. Future investigations might unveil whether the 
presence of Sox2 in ribonucleoprotein complex carries any significance either to the 
functionality of Sox2 or its partner RNAs. 
 
Our results indicate that Sox2 is associated with several complexes in the chromatin and 
nucleoplasm in mouse ES cells, including ribonucleic complexes. While our data suggests 
that the interaction of Sox2 with the ncRNA 7SK does not regulate their recruitment to 
chromatin, it is possible that this crosstalk represents a new facet for the mechanism of action 
of Sox2 in the nucleoplasm and at the chromatin. 
 
 
 
 
Methods 
 
Cell culture 
J1 expressing the biotin ligase BirA and Sox2, Nanog or Oct4 flanked by a peptide amenable 
to biotinylation by BirA, as well as control J1 cells only expressing BirA, were kindly 
provided by Dr. Stuart H. Orkin (Dana Farber, Harvard Medical School) (Kim et al., 2009; 
Wang et al., 2006). Briefly, this in-vivo biotinylation system was set up with a J1 mES cell 
line stably expressing the bacterial BirA gene. BirA-expressing cells were subsequently used 
to introduce a plasmid encoding a peptide-substrate for the BirA enzyme fused to the 
transcription factor of interest, to produce stably expressing biotinylated transcription factor 
(bioTF) mES cell lines.  
 
2TS22C mES cells, where Sox2 can be deleted upon doxycycline treatment, were kindly 
provided by Dr. Hitoshi Niwa at the RIKEN Center for Developmental Biology, Kobe, Japan 
(Masui et al., 2007). All mES cell lines were grown on 0.1% gelatin coated plates and 
maintained in ES media consisting of Glasgow Minimum Essential Medium (GMEM) 
supplemented with 10% fetal calf serum for ESCs (Biosera, Boussen, France), 0.1 mmol/l 
non-essential amino acids, 2 mmol/l L-Glutamine, 1 mmol/l sodium pyruvate, 0.1 mmol/l β-
mercaptoethanol, 1x penicillin/streptomycin and 106 units/l LIF (ESGRO, MilliporeCorp., 
Billerica, MA, USA).  For SILAC experiments, SILAC Advanced DMEM/F12 media was 
used (Invitrogen, SILAC Protein ID and Quantification Kit, MS10033). For Sox2 deletion, 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 10
2TS22C mES cells were treated with 1 µg/ml doxycycline for 24 h. 
 
SILAC quantitative proteomics 
BioSox2 expressing J1 ES cells along control cells were grown in either light (12C6) or heavy 
medium (13C6) for 6 passages. The cells were collected by accutase treatment and washed 
twice with ice-cold PBS. The pellet was resuspended in 5 packed cell volumes (pcv) of ice-
cold nuclear extract buffer A without NP-40 (all buffer compositions are included in 
Supplementary word file 1). After spinning for 10 min at 2,400 g at 4°C, the pellet was 
resuspended in 3 pcv of ice-cold nuclear extract buffer A with NP-40. After incubating the 
cells at 4°C with gentle rotation, they were homogenized with 10 strokes of Dounce 
homogenizer (type B, wheaton 1 ml). Nuclei were pelleted by centrifugation at 4°C for 15 
min at 4,300 g. The resulting supernatant (cytoplasmic fraction) was removed and the pellet 
was resuspended in 2 nuclear pellet volumes (npv) of ice-cold nuclear extract buffer B 
followed by homogenization and extraction of nuclei for 1 h at 4°C with gentle rotation. After 
centrifugation at 13,200 rpm for 30 min, the supernatant (nuclear extract) was transferred to a 
new tube and the pellet (chromatin) was resuspended in 350 µl digestion buffer (Active 
Motif, ChIP-IT Enzymatic Kit, catalogue number 53006) supplemented with 7.9 µl PIC, 7.9 
µl PMSF and 0.875 µl SuperaseIN RNAse inhibitor (ThermoFisher Scientific, AM2696). 
Chromatin samples were incubated for 5 min at 37°C followed by a second incubation for 10 
min at 37°C with shaking at 1,000 rpm after the addition of 1:100 enzymatic working solution 
(Active Motif, ChIP-IT Enzymatic Kit, catalogue number 53006). The reaction was stopped 
with the addition of 7 µl EDTA 0.5 M and the samples were chilled on ice for 10 min. 
Supernatant was collected after centrifugation at 12,000 rpm (4°C) for 12 min and protein 
concentration was measured. Equal amounts of protein from chromatin fractions of control 
and bioSox2 were used for IP. The nuclear extract was ultracentrifuged for 1hr at 60,000 g at 
4°C. Supernatant was collected, protein concentration was measured and equal amounts of 
protein from nuclear fractions of control and bioSox2 were used for IP.  
 
50 µl of Protein G dynabeads (per 5 mg protein) was washed with ice cold nuclear extract 
buffer B (nuclear extract) or digestion buffer (chromatin), resuspended in respective buffers 
and 50 µl was used to pre-clear the extracts for 1hr at 4°C with gentle rotation. 50 µl of 
Dynabeads MyOne Streptavidin T1 (ThermoFisher Scientific) was washed and resuspended 
as previously indicated and 50 µl was added to the pre-cleared supernatant and incubated 
overnight at 4°C with gentle rotation. The beads were washed twice with IP350 0.3 % buffer 
for 15 min with gentle rotation at 4°C, beads from control and bioSox2 were mixed before the 
final wash for both chromatin and nuclear fractions, then were eluted in 2x SDS sample 
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buffer. This was followed by heating at 95°C for 5 min, vortexing, cooling to RT and 
pelleting the beads. The elution was repeated with 1xSDS sample buffer. Supernatants were 
pooled and the beads were pelleted into 4xNuPAGE loading buffer.  Extracted proteins were 
resuspended in Laemmli Sample Buffer, and resolved on a 4-20 % SDS-PAGE. The gel was 
stained with Coomassie blue, cut into 20 slices and processed for mass spectrometric analysis 
using standard in gel procedure. Briefly, cysteines were reduced with dithiothreitol (DTT), 
alkylated using chloroacetamide (CAA) (Nielsen et al., 2008), and finally the proteins were 
digested overnight with endoproteinase Lys-C and loaded onto C18 StageTips prior to mass 
spectrometric analysis. 
 
LC/MS 
All MS experiments were performed on a nanoscale EASY-nLC 1000 UHPLC system 
(Thermo Fisher Scientific) connected to an Orbitrap Q-Exactive Plus equipped with a 
nanoelectrospray source (Thermo Fisher Scientific). Each peptide fraction was eluted off the 
StageTip, auto-sampled and separated on a 15 cm analytical column (75 µm inner diameter) 
in-house packed with 1.9 µm C18 beads (Reprosil Pur-AQ, Dr. Maisch) using a 75 min 
gradient ranging from 5 % to 40 % acetonitrile in 0.5 % formic acid at a flow rate of 250 
nl/min. The effluent from the HPLC was directly electrosprayed into the mass spectrometer. 
The Q Exactive plus mass spectrometer was operated in data-dependent acquisition mode and 
all samples were analyzed using previously described ‘sensitive’ acquisition method 
(Kelstrup et al., 2012). Back-bone fragmentation of eluting peptide species were obtained 
using higher-energy collisional dissociation (HCD) which ensured high-mass accuracy on 
both precursor and fragment ions. 
 
Identification of peptides and proteins by MaxQuant 
The data analysis was performed with the MaxQuant software suite (version 1.3.0.5) as 
described (Cox and Mann, 2008) supported by Andromeda (www.maxquant.org) as the 
database search engine for peptide identifications (Weidner et al., 1990). We followed the 
step-by-step protocol of the MaxQuant software suite (Cox et al., 2009) to generate MS/MS 
peak lists that were filtered to contain at most six peaks per 100 Da interval and searched by 
Andromeda against a concatenated target/decoy (forward and reversed) version of the IPI 
human database. Protein sequences of common contaminants such as human keratins and 
proteases used were added to the database. The initial mass tolerance in MS mode was set to 
7 ppm and MS/MS mass tolerance was set to 20 ppm. To minimize false identifications, all 
top-scoring peptide assignments made by Mascot were filtered based on previous knowledge 
of individual peptide mass error. Peptide assignments were statistically evaluated in a 
Bayesian model on the basis of sequence length and Andromeda score. We only accepted 
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peptides and proteins with a false discovery rate of less than 1 %, estimated on the basis of 
the number of accepted reverse hits. 
 
Gene ontology analysis 
Candidates that showed at least two-fold enrichment over control in the forward and reverse 
labelling in SILAC experiments were considered for analysis. GO analysis was performed  
with  DAVID 6.7 (Huang et al., 2009). P-values were adjusted for multiple hypothesis testing 
using the Benjamini-Hochberg method. Significantly enriched categories in the subontology 
of functional category, pathways and protein domains with an adjusted P-value < 0.05 were 
chosen. 
 
Co-immunoprecipitation of GST tagged HP1 proteins with recombinant Sox2 or ES cell 
nuclear extract 
Recombinant proteins were expressed in and purified from Escherichia coli as described 
previously (Bannister and Kouzarides, 1996). Mouse full-length HP1 isoforms and the 
chromo domain (residues 5–80), hinge (residues 61–121) and chromo-shadow domain 
(residues 110–188) of HP1a were cloned into pGex vector and expressed as a GST fusion 
protein. Glutathione sepharose beads were prepared by washing 1 ml of beads (5 mg GST 
capacity) with 5 ml GST buffer, spinning at for 5 min at 500 g at 4°C and resuspending in 1 
ml GST buffer (50 % slurry, Vf = 2 ml, capacity 2.5 µg/µl). 20 µl 50 % slurry glutathione 
sepharose beads was added to low binding tubes, together with 485 µl GST buffer, 0.5 µg 
recombinant human Sox2 (Abcam ab95847), and 5-10 µg GST, 10 µg GST-HP1α, 10 µg 
GST-HP1β or 10 µg GST-HP1γ. Alternatively, 147.5 µl GST buffer was added to low 
binding tubes, together with 0.5 µg recombinant Sox2 (Abcam ab95847), and 5-10 µg GST + 
2 µl 50 % slurry glutathione sepharose beads, and 10 µg of GST-HP1α-FL, GST-HP1α-
CSD, GST-HP1α-CD, GST-HP1α-H, GST-HP1β-FL, GST-HP1β-CSD, GST-HP1β-CD or 
GST-HP1β-H, in glutathione sepharose beads.  Samples were incubated for 2 h at 4°C with 
end-to-end rotation, spinned for 5 min at 500 g at 4°C. Beads were washed four times with 1 
ml GST lysis buffer (with spins for 5 min at 500 g at 4°C). GST fusion and bound proteins 
were eluted with 30 µl 2xLaemmli buffer and boiled for 5 min, prior to western blot.  
 
For co-IPs with mouse ES cell nuclear extracts (isolated as described in the quantitative 
proteomics section), these were pre-cleared and RNAse treated by incubating 25 µg GST 
protein, 20 µl 50 % slurry glutathione sepharose beads (50 µg capacity), 200 µg Oct4 GIP ES 
nuclear extracts, 5 µl RNase A (2.5 g, DNase-free, Roche #11119915001) or dH2O, and GST 
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buffer. Samples were incubated for 1 h at room temperature and centrifuged for 5 min at 500 
g at 4°C. The pre-cleared supernatants were then mixed with 20 µl 50 % slurry glutathione 
sepharose beads, and 5-10 µg GST, 10 µg GST-HP1α, 10 µg GST-HP1β or 10 µg GST-HP1γ 
in glutathione sepharose beads. Samples were incubated for 2 h at 4°C and centrifuged for 5 
min at 500 g at 4°C. Beads were washed twice with 1 ml GST lysis buffer and twice with 0.5 
ml GST lysis buffer (with spins for 5 min at 500 g at 4°C).  GST fusion and bound proteins 
were eluted with 30 µl 2xLaemmli buffer and boiled for 5 min, prior to western blot. 
 
Western blot 
Cell monolayers or pellets were resuspended in 2xLaemmli buffer, boiled for 5 min at 95°C 
and passed 10 times through a 21 G needle to shear genomic DNA. Proteins were separated 
by SDS–PAGE, transferred to nitrocellulose membrane (Millipore) using wet transfer and 
incubated in blocking solution (5 % BSA in TBS containing 0.1 % Tween) for 1hr at room 
temperature. Membranes were incubated with primary antibody at 4°C overnight and 
appropriate HRP-conjugated secondary antibody for 2 h at room temperature. Membranes 
were then incubated for chemiluminescence (ECLH; GE Healthcare) and proteins were 
detected by exposure to X-ray film. Primary antibodies, diluted in blocking solution were 
used against Sox2 (α-Sox2, raised in goat, Y-17, Santa Cruz, sc-17320). 
 
RNA immunoprecipitation (RIP) and sequencing 
All incubations were performed in low-bind RNase-free tubes. 50 million cells/IP were fixed 
with 1 % formaldehyde (Sigma F8775) for 10 min at room temperature, quenched with 
Glycine stop solution (Active Motif, ChIP-IT Enzymatic Kit, catalogue number 53006) and 
lysed. The total nuclear lysate was either sonicated at high frequency (H 20W) with the 30 s 
ON/30 s OFF setting for 20 min in BioRuptor or processed for nuclei isolation and enzymatic 
digestion, as described for the SILAC quantitative proteomics (Active Motif, ChIP-IT 
Enzymatic Kit, catalogue number 53006). Sheared chromatin was pre-cleared with Protein G 
Dynabeads for 1 h at 4°C with gentle rotation. Immunoprecipitation of biotinylated 
Sox2/Oct4/Nanog was performed with 50 µl MyOne streptavidin Dynabeads T1 overnight 
followed by washing with FA1000, LiCl and TES buffers. RNA was eluted after reverse-
crosslinking (65°C for 1 h with 1,000 rpm rotation), Qiazol was added and RNA was 
extracted using the Qiagen miRNAeasy kit. Sample preparation for sequencing was done by 
either adapting the directional mRNA-Seq protocol (Illumina RS-100-0801) to the small 
RNA Illumina sequencing, v1.5 small RNA 3’ adaptor kit (Illumina FC-102-1009) or by 
using TruSeq directional small RNA kit (Illumina RS-200-0012).  In order to capture both 
long and short RNAs, RNA was fragmented (Ambion AM8740) prior to sample preparation. 
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Total RNA was depleted from ribosomal RNA by treatment with Ribo-Zero rRNA removal 
kit (RZH1086). Sequencing was performed with Illumina instruments to obtain single-end or 
paired-end reads (Supplementary Table 3).  For endogenous RIPs, the following antibodies 
were used: mouse∝-FLAG M2 (Sigma), Sox2 (α-Sox2, raised in goat, Y-17, Santa Cruz, sc-
17320), Nanog Antibody AbVantage Pack (Bethyl, A310-110A), Mouse KLF4 Affinity 
Purified Polyclonal Ab, Goat IgG (AF3158, R&D Systems), Oct-3/4 (N-19) X, Polyclonal 
Antibody (sc-8628-X, Santa Cruz) and Suz12 (Abcam, ab12073). 
 
RNA-seq data processing and analysis 
RNA-seq data from RIP and input samples were processed in the same manner, using the 
best-practice RNA-seq pipeline from the National Genomics Infrastructure Sweden (NGI-
RNAseq v1.4; https://github.com/SciLifeLab/NGI-RNAseq), including adapter trimming with 
cutadapt v1.16 (Martin, 2011), mapping to mouse genome assembly GRCm38 with STAR 
v2.5.3a (Dobin et al. 2013), counting reads per gene (Ensembl release 92 annotation) with 
featureCounts v1.6.0 (Liao et al., 2014), and multiple quality control steps. Read counts were 
normalized among samples using the size factor method implemented in the BioConductor 
package DESeq2 (Anders and Huber, 2010). To identify differences in gene expression 
between bioSox2 and control J1 cells, the input samples were compared using DESeq2 
v1.22.2 with default parameters, including experimental batch as a factor to account for 
differences in library preparation and sequencing between the two batches. P-values were 
adjusted by the Benjamini-Hochberg method to control the false discovery rate (FDR). To 
identify RNAs enriched by RIP, an enrichment ratio was computed per batch, as (bioSox2 
RIP / control RIP) / (bioSox2 input / control input), using normalized counts incremented by a 
pseudo-count of 0.1 to avoid denominators of zero. RNAs with enrichment ratio > 2 and 
bioSox2 RIP raw read count > 50 in both batches were considered hits. 
 
qRT-PCR 
Total RNA was extracted using the miRNeasy Extraction Kit (Qiagen), with in-column 
DNAse treatment. 500 ng of RNA was reverse transcribed using the High capacity cDNA 
reverse transcription kit (4368814, Applied Biosystems) including RNase inhibitor 
(N8080119, Applied Biosystems). A reverse transcriptase negative (RT-) control was 
included for each sample. Both the cDNA and the RT- were diluted 1:3 in RNase/DNAse free 
water for qRT-PCR. qRT-PCR reactions were run on a StepOnePlus™ System (Applied 
Biosystems) in duplicate and with RT- reactions to control for genomic DNA. Fast SYBR® 
Green Master Mix (4385616, Applied Biosystems) was used according to the manufacturer’s 
instructions; each PCR reaction had a final volume of 10 µl with 2.5 µl of diluted cDNA or 
RT-. The running conditions were 20 s at 95˚C, followed by 40 cycles of 3 s of 95˚C and 30 s 
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of 60˚C, then 15 s at 95˚C, 1 min at 60˚C and 15 s at 95˚C.  Tbp was run as housekeeping 
gene. Double delta Ct method was used for calculating fold change. 
 
 
Chromatin Isolation by RNA Purification (ChIRP) 
ChIRP was performed as previously described (Chu et al., 2012). Mouse 2TS22C cells were 
cultured as above and either treated with Dimethyl sulfoxide (DMSO) or Doxycycline (1 
µg/ml) for 24 h before cross-linking with glutaraldehyde. 20 million cells were used per 
ChIRP. Six probes covering the whole length of 7SK were used and depending on their 
positions along the RNA were divided into odd and even probe pools (Flynn et al., 2016). A 
single probe against LacZ mRNA was used as a negative control.  Isolated RNA from a small 
aliquot of post-ChIRP beads was used in qRT-PCR to quantify 7SK enrichment. Isolated 
DNA following ChIRP was used to make sequencing library with ThruPLEX DNA-seq 12S 
kit (R400428, Rubicon Genomics). The library was quantified with KAPA library 
quantification kit (Illumina), samples were pooled and then sequenced on HiSeq2500 at 
National Genomics Infrastructure (NGI), SciLife Lab, Stockholm. 
 
ChIRP-seq data analysis  
Sequence reads were trimmed using trim_galore (Krueger, 2012) to remove adapter 
sequences and low quality bases from the 3' end of the reads. Reads less than 20 bp (n1) or 40 
bp (n2) were removed post-trimming, prior to mapping. Trimmed reads were mapped to the 
mm10 mouse genome from the UCSC database using bwa  (Li and Durbin, 2009) with 
parameters -n 3 -k 2 -R 300. Peak calling was performed for each ChIRP pulldown using 
macs2 (Zhang et al., 2008) with parameter -q 0.001 using the corresponding Input sample as 
control. Downstream analyses were conducted using the Bioconductor suite of packages 
(Huber et al., 2015) in R (R core team, 2017). Each treatment was conducted in duplicate, and 
only peaks that overlapped between the two pulldowns for each treatment were taken forward 
in the analysis. Robust 7SK binding sites were identified by taking the overlap between the 
peaks called using the odd and even probe pools. Peaks that also overlapped a peak from the 
LacZ negative control were removed. A final set of 7SK binding sites was identified by 
taking the union between the doxycycline treated and untreated filtered probe sets. 
Annotation of our peaks and those from external data sets was performed against the UCSC 
mm10 knownGene database using the clusterProfiler package (Yu et al., 2012). Target genes 
were identified based on overlap of significant peaks with either the gene body or the 
promoter region defined as the region 2.5 Kb upstream of the TSS. Quantification of ChIRP 
signal at loci of interest was performed using modified scripts from the Repitools package 
(Statham et al., 2010).  
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Chromatin Immunoprecipitation (ChIP) 
Briefly 300,000 2TS22C cells were plated per condition in a 6-well plate. 100 nM of 
scrambled ASO or 7SK 3’ ASO (IDT) were transfected using Lipofectamine 2000 
(Invitrogen) using the manufacturer’s recommendations. Opti-MEM reduced serum medium 
was used to prepare the complexes. Cells were incubated with these complexes overnight 
before replacing with fresh medium. After 24 h, cells were either collected into Qiazol 
(Qiagen) for RNA extraction or were cross-linked with 1 % formaldehyde (37 %, Sigma-
Aldrich) for ChIP.  
 
The protocol and buffers from the True MicroChIP kit (C01010130, Diagenode) were used to 
perform sonication and immunoprecipitation (IP) with 100,000 cells per condition. Cells were 
sheared for 25 min using Bioruptor (Diagenode) with 30s ON/30s OFF setting under high 
power (H). 0.5 µg of Sox2 antibody (AF2018, R&D) or goat IgG was used for each IP. The 
immune complexes were purified with DiaMag Protein G coated magnetic beads 
(C03010021, Diagenode).  De-crosslinked DNA was eluted for qPCR to assess changes in 
Sox2 recruitment to specific areas of interest following 7SK knock down. To compare Sox2 
recruitment between control and 7SK depleted cells, the qPCR data was normalized to 10 % 
purified input DNA, which was used as a measure of total chromatin present in the particular 
sample.
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Figure legends 
Figure 1 
A) Schematic representation of the strategy used to characterize Sox2 protein 
interactome by Stable Isotope Labelling by Amino acids in Cell culture (SILAC) 
followed by Mass spectroscopy (MS). Control and bioSox2 J1 ES cell lines were 
cultured with either LIGHT (12C6) or HEAVY (13C6) medium, respectively. Native 
chromatin and nucleoplasm extracts were prepared from these cells and the protein 
interactome of Sox2 was immunoprecipitated and mixed prior to MS for proteomic 
analysis. 
B) Western blot showing successful pull down and an enrichment of bioSox2 after 
immunoprecipitation in both chromatin and nucleoplasm fractions, compared to the 
control. 
C) 2D interactome plot representing the fold change of identified proteins interacting 
with bioSox2 in the nucleoplasm. Ratios are represented in a logarithmic scale with 
(H/L) on X axis plotted against (L/H) on Y. 
D) 2D interactome plot representing the fold change of identified proteins interacting 
with bioSox2 in the chromatin. Ratios are represented in a logarithmic scale with 
(H/L) on X axis plotted against (L/H) on Y. 
E) Gene Ontology (GO) analysis for significant protein interactors of Sox2 in the 
nucleoplasm fraction of J1 ES cells. Represented in the figure are the non-redundant 
GO terms found over-represented by modified Fisher exact test with Bonferroni 
corrected P-values 
F) GO analysis for significant protein interactors of Sox2 in the chromatin fraction of J1 
ES cells. Represented in the figure are the non-redundant GO terms found over-
represented by modified Fisher exact test with Bonferroni corrected P-values. 
 
Figure 2 
A) Schematic representation of the strategy used to characterize RNA interactome of 
Sox2 by RNA-immunoprecipitation followed by sequencing (RIP-seq). Cells from 
control and bioSox2 J1 ES cell line were fixed with 1 % formaldehyde to capture 
direct and indirect RNA-bioSox2 interactions. Nuclei were pelleted and RNA was 
enzymatically digested. BioSox2-bound RNA was immunoprecipitated with 
streptavidin beads and the final eluted RNA was Ribo-Zero treated to remove 
ribosomal RNA, before sequencing. 
B) IGV screenshot of Rpl13a gene from one RIP-Seq experiment showing normalized 
read counts from sequenced RNA in control and Sox2-BirA (bioSox2) samples, 
following RIP-seq. Snord34 reads are over-represented in bioSox2 compared to the 
control (indicated by an arrow). Neighboring Snord35 does not show any such over-
representation. 
C) IGV screen shot of D6Wsu163e gene from one RIP-Seq experiment showing 
normalized read counts from sequenced RNA in control and Sox2-BirA (bioSox2) 
samples, following RIP-seq. D6Wsu163e reads are over-represented in bioSox2 
compared to the control sample. 
D) IGV screen shot of Rn7SK gene from one RIP-Seq experiment showing normalized 
read counts from sequenced RNA in control and Sox2-BirA (bioSox2) samples, 
following RIP-seq. Rn7SK reads are over-represented in bioSox2 compared to the 
control sample. 
E) Table showing all RNAs with enrichment ratio > 2 and bioSox2 RIP raw read count > 
50 in two RIP-seq experiments combined. Enrichment ratios were computed as 
(bioSox2 RIP / ctrl RIP) / (bioSox2 input / ctrl input), using normalized counts 
incremented by a pseudo-count of 0.1 (to avoid denominators of zero). For more 
details, see Supplementary Table 4. 
 
Figure 3 
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A) Schematic representation of Chromatin Isolation by RNA Purification (ChIRP) 
strategy to assess global recruitment of 7SK to the chromatin following Sox2 KO. 
Doxycycline inducible Sox2 KO 2TS22C mES cells were treated with 1 µg/ml 
doxycycline or DMSO for 24hrs. Western blot with 30 ng of protein extract from 
doxycycline treated and untreated cells shows a deletion of Sox2 in the treated 
samples. Sox2 null and WT 2TS22C cells were cross-linked with glutaraldehyde, 
sonicated and hybridized to 7SK odd and even biotinylated pools (three probes per 
pool) or a single biotinylated probe against LacZ mRNA. Streptavidin beads were 
used to pull down DNA bound by 7SK and then sequenced. 
B) RT-qPCR showing percent RNA pulled down following ChIRP with 7SK odd and 
even pools in Sox2 null and WT mES cells (n=2). Error bars indicate SD. 7SK is 
pulled down specifically with varying efficiencies by the 7SK odd and even pool 
compared to the LacZ control. Neither Gapdh nor Malat1 RNA show any significant 
enrichment with 7SK odd and even pools in both the conditions. 
C) Comparison of global genomic 7SK binding in WT and Sox2 null conditions in 
2TS22C cells. Heat map showing ChIRP-seq signal, normalized to read depth, +/- 5 
Kb around peak mid-points common to 7SK odd and even data sets in Sox2 null and 
WT samples from two independent ChIRP experiment. There is no significant change 
in global genomic 7SK recruitment following Sox2 ablation.  
 
Figure 4 
A) Schematic representation of a Chromatin immunoprecipitation (ChIP) experiment 
following 7SK knock down in 2TS22C mES cells. An ASO targeting 3’ end of 7SK 
was used to knock down 7SK. Control cells were treated with a scrambled ASO. The 
resulting cells were fixed with 1% formaldehyde, sonicated, and chromatin from 
about 100,000 cells was used for immunoprecipitation with an antibody against 
endogenous Sox2. This was followed by affinity purification of immune complexes 
with Protein G beads. The DNA was de-crosslinked and eluted prior to qPCR 
analysis. 
B) Normalized ChIRP-seq read distribution centered on the Sox2 binding peaks from 
Whyte et al. dataset shows no co-binding of 7SK at Sox2-bound loci. 
C) Venn diagram showing an overlap of genes among three datasets, namely Sox2 ChIP 
Whyte dataset, 7SK ChIRP Flynn dataset and the ChIRP dataset produced in this 
study. The numbers in the intersections denote the number of unique genes associated 
with each factor, either in the gene body or in the promoter. 
D) RT-qPCR showing fold change in 7SK expression 24 h post-transfection with 100 
nM of 7SK 3’ ASO compared to the control treated with a scrambled ASO.  Error 
bars indicate SEM (n=3) 
E) ChIP-qPCR results showing enrichment of Sox2 bound DNA as percent input in 
2TS22C cells treated with control and 7SK 3’ ASO at regulatory regions of Pou5f1 
(Oct4), Nanog, Kdm2b, Celf2, Klf12 and Dll1. Amplification in goat IgG was used as 
a measure of background for the specific regions assayed. Sox10 intron was used as a 
negative control. Error bars indicate SEM (n=3), each point is a biologically 
independent experiment (knock-down) that represents an average of triplicate or 
duplicate ChIP experiments.  
 
Supplementary figure 1 
A) Gene expression correlation between control and bioSox2 mES J1 cell lines measured 
by RNA-seq. Normalized read counts are plotted for all detected genes, comparing 
the control and bioSox2 input samples (mean across the two experiments). Red 
circles indicate differentially expressed genes (FDR-adjusted P < 0.1), listed in 
Supplementary Table 1. 
B) Mass-spectrometric chromatogram of HP1 peptide showing peaks from LIGHT 
amino acid labelled control (red) and HEAVY amino acid labelled bioSox2 (blue) 
chromatin extracts. 
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C) Western blot indicating pull down of Sox2 in co-immunoprecipitation experiments 
with GST-tagged HP1 α, β, γ proteins and recombinant human Sox2, compared to the 
control. (n=2 for HP1α) 
D) Representative western blot indicating pull down of Sox2 from ES nuclear extract in 
immunoprecipitation experiments with GST-tagged HP1 α, β, γ proteins in the 
presence or absence of RNase (n=2 for HP1α and β) 
E) Western blot indicating successful pull down of Sox2 in co-immunoprecipitation 
experiments with different GST-tagged domains of HP1 α, β proteins (FL-full length, 
CSD-chromo shadow domain, CD-chromo domain) and recombinant human Sox2. 
Different domains of HP1 proteins exhibit varying affinities for Sox2 (n=1) 
F) RT-qPCR showing enrichment of 7SK and Snord34 RNAs pulled down in ES cell 
following (left) RNA immunoprecipitation with biotin tagged Sox2 and other 
pluripotency factors, bioOct4 and bioNanog; Y-axis, % of input (right); RNA 
immunoprecipitation of endogenous proteins with antibodies against Sox2, Oct4, 
Nanog, Klf4 and Suz12. Y-axis, fold enrichment to FLAG IP.   
G) RT-qPCR showing enrichment of Sox2, Pou5f1 (Oct4), Nanog and Suz12 mRNAs 
pulled down in ES cell following (above) RNA immunoprecipitation with biotin 
tagged Sox2 and other pluripotency factors, bioOct4 and bioNanog; Y-axis, % of 
input (below); RNA immunoprecipitation of endogenous proteins with antibodies 
against Sox2, Oct4, Nanog, Klf4 and Suz12. Y-axis, fold enrichment to FLAG IP.   
H) Comparison of global genomic 7SK binding in WT and Sox2 null replicate 
conditions in 2TS22C cells. Heat map showing ChIRP-seq signal, normalized to read 
depth, +/- 5 Kb around peak mid-points common to 7SK odd and even data sets in 
Sox2 null and WT samples. There is no significant change in global genomic 7SK 
recruitment following Sox2 ablation in both the replicates. 
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Highlights 
 
• Samudyata et al. present a Sox2 protein interactome resource in 
chromatin and nucleoplasm of mouse embryonic stem cells 
• Sox2 interacts with RNA-binding proteins and ncRNAs, including 7SK 
and Snord34 
• Loss of Sox2 does not significantly alter genomic binding profiles of 7SK 
• Loss of 7SK does not significantly affect Sox2 binding in regulatory 
regions co-occupied by both transcriptional regulators. 
 
